Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round

New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of...

Related Keywords

Munich ,Bayern ,Germany ,Switzerland ,Milan ,Lombardia ,Italy ,United States ,France ,Paris ,France General ,French ,Sylvie Berrebi ,Marina Udier ,Pasteur Mutualit ,Rick Davis ,Goran Ando ,Hakan Goker ,Thibaut Roulon ,Society For Immunotherapy Of Cancer ,National Cancer Institute ,Linkedin ,Janssen Research Development ,Andera Life Sciences ,Bandera Co ,Boehringer Ingelheim ,European Fund Of Investment ,Life Sciences ,Bristol Myers Squibb ,Merck Co Inc ,Frontier Technology Sustainability ,Andera Partners ,Revelation Partners ,Indaco Venture Partners ,Nouscom Board ,Microsatellite Instable ,Metastatic Colorectal Cancer ,Lynch Syndrome ,Late Breaking Abstract ,Chief Executive Officer ,Independent Chairman ,Board Members ,Sofia Ioannidou ,Senior Investment Director ,Managing Director ,Biotechnology Investments ,Andera Midcap ,Andera Co Invest ,Andera Acto ,Andera Infra ,Andera Partner ,European Fund ,Life Science ,Frontier Technology ,Myeloproliferative Neoplasms ,Janssen Research ,Bristol Myers ,Mark Swallow ,